CLINUVEL PHARMACEUTICALS LIMITED

0.19%

$10.68

Market Cap $535.3M

Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on... Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Latest Threads

Tag

Subject

CUV

Why CUV so cheap?

13:57

2.4K

13:57

Last post TheAnalyst007

2.4K

CUV

Price Target: > $200 per share

11/09/25

2.5K

11/09/25

Last post ironbark222

2.5K

CUV

Shorts cover 1.3 million shares of CUV in 1 day! - NEXT STOP $200!

11/09/25

880

11/09/25

Last post Eagle0

880

CUV

No chance of Cap Raise

10/09/25

974

10/09/25

Last post ironbark222

974

CUV

Cap Raise

10/09/25

4.0K

10/09/25

Last post Eagle0

4.0K

CUV

Ann: CLINUVEL delivers ninth consecutive revenues growth & profit

2 3

08/09/25

124

31K

08/09/25

Last post TheAnalyst007

124

31K

CUV

EMA Update

08/09/25

19K

08/09/25

Last post Silverchair

19K

CUV

Ann: Chair's Letter to Shareholders

07/09/25

5.4K

07/09/25

Last post minutesoup

5.4K

See All Discussions

Timeline

Chair's Letter to Shareholders
05 Sep 09:01	Share

Date of Annual General Meeting
03 Sep 09:15	Share

CLINUVEL Annual Results - Investor Webinar
29 Aug 09:08	Share

Investor Presentation
28 Aug 09:37	Share

Corporate Governance Statement
28 Aug 09:36	Share

Appendix 4G
28 Aug 09:36	Share

Dividend/Distribution - CUV
28 Aug 09:36	Share

CLINUVEL delivers ninth consecutive revenues growth & profit
28 Aug 09:35	Share

Appendix 4E and Annual Report to Shareholders 2025
28 Aug 09:34	Share

CLINUVEL preparing upgrade of ADR program, NASDAQ uplist
22 Aug 09:30	Share

CLINUVEL Annual Results - Investor Webinar
21 Aug 12:17	Share

Bioshares Biotech Summit presentation
07 Aug 09:24	Share

Presentation to BTIG Biotech Conference
30 Jul 12:06	Share

Notification of cessation of securities - CUV
02 Jul 08:21	Share

German Non-deal Roadshow Presentation
24 Jun 08:45	Share

Ceasing to be a substantial holder
19 Jun 08:16	Share

Study confirms NB-UVB needed to activate repigmentation
18 Jun 09:35	Share

Becoming a substantial holder
18 Jun 08:19	Share

CLINUVEL management update
13 Jun 09:35	Share

SCENESSE successfully administered to paediatric EPP patient
13 Jun 08:58	Share

SCENESSE in Vitiligo - A Global Update
04 Jun 10:07	Share

SCENESSE EPP data featured at EADV Symposium
22 May 08:57	Share

Ceasing to be a substantial holder
09 May 08:24	Share

CUV recruits 200 patients in Phase III vitiligo trial CUV105
07 May 08:41	Share

Notification regarding unquoted securities - CUV
23 Apr 09:00	Share

Notification of cessation of securities - CUV
09 Apr 08:22	Share

Section 708A Cleansing Statement
07 Apr 08:55	Share

Application for quotation of securities - CUV
07 Apr 08:51	Share

Application for quotation of securities - CUV
07 Apr 08:49	Share

Change in substantial holding
01 Apr 19:43	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $10.68		Change 0.020(0.19%)		Mkt cap ! $535.3M

Open	High	Low	Value	Volume
$10.80	$10.80	$10.55	$827.0K	77.42K

Buyers (Bids)

No.	Vol.	Price($)
9	300	$10.67

Sellers (Offers)

Price($)	Vol.	No.
$10.69	466	11

View Market Depth

No.	Vol.	Price($)
14	390	10.680
4	156	10.670
5	200	10.660
6	464	10.650
6	3013	10.640

Price($)	Vol.	No.
10.690	317	7
10.700	256	5
10.710	190	4
10.720	448	8
10.730	354	6

Last trade - 13.56pm 12/09/2025 (20 minute delay)


Last $10.69		Change 0.020 ( 0.07 %)
Open	High	Low	Volume
$10.63	$10.76	$10.60	7717
Last updated 14.15pm 12/09/2025 ?

CUV (ASX) Chart

CLINUVEL PHARMACEUTICALS LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Clinuvel shares dip, even as CEO comes back from temp leave

After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...

Clinuvel stroke drug shows 'positive' results – but some adverse effects left unclear

Clinuvel shares jumped on Tuesday on higher volumes as the company reported a clinical trial win with its stroke drug, 'PRENUMBRA.'

British study shows Clinuvel drug effective on DNA of UV-damaged skin

Clinuvel Pharmaceuticals Ltd has reported final results of its study of the efficacy of afamelanotide to repair the DNA of damaged skin.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News